Yale University School of Medicine, Alzheimer's Disease Research Unit — New Haven, Connecticut

Yale University School of Medicine, Alzheimer's Disease Research Unit is a clinical research site located in New Haven, Connecticut, United States 06510.

Crixeo Health Trust Score: 62/100 (FAIR). This profile has not yet been claimed by the site owner.

Yale University School of Medicine, Alzheimer's Disease Research Unit has participated in 4 clinical trials.

Therapeutic areas: Alzheimer's Disease, Alzheimer Disease.

Sponsors: OPKO Health, Inc., JANSSEN Alzheimer Immunotherapy Research & Development, LLC, Pfizer.

Sponsor Feasibility Report

Trust Score: 62/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Yale University School of Medicine, Alzheimer's Disease Research Unit?

Yale University School of Medicine, Alzheimer's Disease Research Unit has a Crixeo Trust Score of 62/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Yale University School of Medicine, Alzheimer's Disease Research Unit conducted?

Yale University School of Medicine, Alzheimer's Disease Research Unit has 4 clinical trials on record. Their work covers Alzheimer's Disease, Alzheimer Disease.

Is Yale University School of Medicine, Alzheimer's Disease Research Unit accredited by Crixeo Health?

Yale University School of Medicine, Alzheimer's Disease Research Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Yale University School of Medicine, Alzheimer's Disease Research Unit?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.